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Molecular determinants underlying interferon (IFN)-macrophage biology can help
delineate enzyme systems, pathways and mechanisms for enabling host-directed
therapeutic approaches against infection. Notably, while the IFN antiviral response
is known to be directly coupled to mevalonate-sterol biosynthesis, mechanistic
insight for providing host pathway-therapeutic targets remain incomplete. Here, we
show that Nampt and Sirt6 are coordinately regulated upon immune activation of
macrophages and contribute to the IFN-sterol antiviral response. In silico analysis of
the Nampt and Sirt6 promoter regions identified multiple core immune gene-regulatory
transcription factor sites, including Stat1, implicating a molecular link to IFN control.
Experimentally, we show using a range of genetically IFN-defective macrophages
that the expression of Nampt is stringently regulated by the Jak/Stat-pathway while
Sirt6 activation is temporally displaced in a partial IFN-dependent manner. We further
show that pharmacological inhibition of Nampt and small interfering RNA (siRNA)-
mediated inhibition of Nampt and Sirt6 promotes viral growth of cytomegalovirus in
both fibroblasts and macrophages. Our results support the notion of pharmacologically
exploiting immune regulated enzyme systems of macrophages for use as an adjuvant-
based therapy for augmenting host protective pathway responses to infection.
Keywords: cholesterol, metabolism, lipid pathway, sterol, epigenetic, interferon, cytomegalovirus
INTRODUCTION
Infection is a dynamically complex and multifaceted process requiring not only the avoidance of
immune countermeasures but also the exploitation of host cellular networks and machinery by the
pathogen. In many cases, parastization by pathogens and especially by viruses requires remodeling
of metabolic and energy resources for the successful production of progeny. Notably, the immune
system has been found to cross regulate these resources and processes as an evolutionary selected
countermeasure. For example, IFNγ induced consumption of tryptophan, by the Indoleamine 2,3
Dioxygenese (IDO) pathway, has been shown to inhibit replication of several intracellular organism
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including hCMV (Pfefferkorn, 1984; Carlin et al., 1989;
MacKenzie et al., 1998; Bodaghi et al., 1999; Heseler et al., 2013).
More recently interferon regulation of the sterol biosynthesis
pathway has been shown to be a central biosynthetic pathway
targeted by the immune system for broad host-protection
against infection.
In this scenario, Toll-like receptor activation of macrophages
by pathogens leads to the production of type I interferons which
coordinately regulate a marked and sustained reduction in the
mevalonate-sterol biosynthetic pathway, and whereby a wide-
spectrum of different human and animal viruses have been
shown to be sensitive to suppression of the pathway (Adams
et al., 2004; Gerbod-Giannone et al., 2006; Eguchi et al., 2008;
Zhu et al., 2008; Bauman et al., 2009; Maitra et al., 2009;
Haas and Mooradian, 2010; Blanc et al., 2011; Olsen et al.,
2011; Chukkapalli et al., 2012; Liu et al., 2013; Mesmin et al.,
2013; Reboldi et al., 2014; Singaravelu et al., 2015; Robertson
et al., 2016). The currently known molecular pathways for
down-regulating the sterol pathway involve the IFN induction
of an hydroxylase enzyme (Ch25h) and its cognate regulatory
metabolite, 25-hydroxycholesterol (25HC) that potently inhibits,
at the protein level, the master transcription factor (TF) for
sterol biosynthesis (SREBP2) (Blanc et al., 2013), and also the
key regulated mevalonate reductase, HMGCR (Lu et al., 2015),
and additionally IFN regulated microRNAs (miR342-5p), that
coordinate changes in the enzymatic flux of the cholesterol
pathway within the cell (Robertson et al., 2016). However,
there remains yet to be identified transcriptional or epigenetic
mechanisms for suppression of SREBP2 and sterol biosynthesis.
More broadly, there is increasing evidence showing
connections between immune signaling, such as interferon
(IFN) signaling, and the regulation of sterol, sugar, and fatty
acid metabolism (Zelcer and Tontonoz, 2006; Spann and Glass,
2013; Kotzamanis et al., 2015; York et al., 2015). While the cell
typically induces changes through rapid established routes such
as the PI3K/AKT/mTOR signaling pathway, these changes are
not sustained over a longer period time and do not support
the increased needs for de novo lipogenesis. In the context of
cellular stress and inflammation, Sirtuins (SIRTs) are known to
play sustained roles in protecting against cellular stress through
epigenetic control of metabolic pathways (Lyssiotis and Cantley,
2012; Jiang et al., 2013). This includes the regulation of glycolytic
and lipid metabolism by the nicotineamide adenine dinucleotide
(NAD+)-dependent deacetylases SIRT1 and SIRT6 (Liu et al.,
2012a,b; Elhanati et al., 2013; Tao et al., 2013). Metabolic coupling
is strictly dependent on NAD+ production through de novo
biosynthesis from tryptophan or through the nicotineamide
(NAM) salvage pathway, which is regulated by the rate-limiting
enzyme nicotineamide phosphatidyltransferase (NAMPT). It
is notable that NAD+-dependent activation of SIRT6 has been
shown to repress the SREBF2 promoter (Elhanati et al., 2013),
and thereby directly linking SIRT6 activity to sterol metabolism.
However, whether NAMPT or SIRT6 are coordinately regulated
by the IFN macrophage antiviral response is not known. Most
notably this remains a central unanswered question to the
notion of using macrophage interferon biology as a guiderail for
identifying host-directed druggable targets as anti-infectives.
In the present report, we find that Nampt and Sirt6 are
coordinately regulated upon immune activation of macrophages
and contribute to the interferon antiviral response. The coupling
to the IFN response is via direct transcriptional activation of
NAMPT through the JAK/STAT signaling pathway. We show
that pharmacological inhibition of Nampt and small interfering
RNA (siRNA)-mediated inhibition of Nampt and Sirt6 enhances
the viral growth of cytomegalovirus (mCMV) in both fibroblasts
and macrophages. These findings support the proposition that
immune regulated enzyme systems may be used as an adjuvant
therapy for augmenting the host protective response to infection.
RESULTS
Co-ordinate Regulation of Nampt and
Sirt6 Are Part of the Interferon-Metabolic
Anti-viral Response
We first investgated whether murine Nampt and Sirt6 and human
NAMPT and SIRT6 promoter regions contained any putative
transcriptional binding sites (TFBS) for immune-regulatory TFs
(Figure 1 and Supplementary Tables S1–S4). By using the
sequence analysis tool PROMO (Messeguer et al., 2002; Farré
et al., 2003), and manual procurement by comparing putative
binding sites to published consensus binding sequences, an array
of significant binding sites (restricted to 15% dissimilarity) for
core immune-activated TFs, including AP-1, NFκB (defined here
as DNA binding activity constituted either by p50 homodimer, a
p50/p65 heterodimer, or a heterotetramer), RELA (p65 subunit
of NFκB), GATA1 and GATA2, were identified within (−1 kb
upstream of) the murine Nampt and Sirt6 promoter regions
(Figure 1). PROMO analysis of the human NAMPT and SIRT6
promoter regions identified similar binding sites, suggesting
that the overall activation mode of these genes is conserved
between humans and mice. Notably, several putative Signal
Transducers and Activators of Transcription 1 (STAT1) sites were
identified across the Nampt promoter region, suggesting Nampt
expression might be driven directly by the activation of the
JAK/STAT signaling pathway (Figure 1). A putative Oct cluster
[OCT1/2/(3/4)] was also identified in the distal Nampt promoter
region, in close proximity to putative NFκB, RELA, and STAT1
binding sites. While the promoter region of Sirt6 did not contain
any putative STAT1 binding sites, it was dominated by putative
binding sites for Activator protein 1 (AP-1), c-JUN, c-FOS, and
NFκB. The AP-1 structure is a heterodimer composed of proteins
belonging to the c-FOS, c-JUN, Activating transcription factor
(ATF), and Jun dimerization protein (JDP) families (Angel and
Karin, 1991; Karin et al., 1997). Consistent with its reported
activity, the putative AP-1 binding sites were found in close
proximity to either c-FOS, c-JUN, or in areas containing cis-
located c-FOS and c-JUN binding sites (Figure 1). AP-1, an early
response TF, has been reported to regulate gene expression in
response to various stimuli, including cytokine stimulation and
bacterial and viral infections (Hess et al., 2004).
The presence of several putative immune-gene regulatory
TF binding sites, prompted us to investigate whether Nampt
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FIGURE 1 | Putative transcription factor (TF) binding sites within the promoter regions of murine Nampt and Sirt6 and human NAMPT and SIRT6. In silico analysis
using PROMO of the murine Nampt and Sirt6 and human NAMPT and SIRT6 promoter regions revealed putative binding sites for an array of different
immune-regulatory TFs (Supplementary Tables S1–S4). The cut off for dissimilarity to the consensus TF binding-sequence was set to 15% (∗ marks binding
sites with low percentage, 0–4%, dissimilarity) and the identified string sequences were compared to the consensus binding site sequences for each TF. Figure is
not to scale.
FIGURE 2 | Expression of Nampt and Sirt6 is upregulated by MCMV infection. (A) Quantification of relative Nampt and Sirt6 mRNA expression in NIH-3T3 cells, at 6
and 10 h, using RT-qPCR following mCMV infection with mock-infected cells serving as controls (n = 3). (B) Quantification of relative Nampt and Sirt6 mRNA
expression in p53-MEF cells, at 3 and 6 h, using RT-qPCR following mCMV infection (n = 3). ANOVA with Tukey post-test was used to assess statistical signficance.
(C) Normalized temporal Nampt and Sirt6 expression (antilog) in mCMV infected bone marrow derived macrophages (BMDM). The expression was measured over
the first 24 h of infection using microarray and compared to timepoint 0. The expression levels between 0 and 10 h were smoothened and fitted to a linear (+),
quadatic (#), or cubic (∗) polynomal on time and the statistical significance (p-values) was assessed. +/#/∗p < 0.05, ++/##/∗∗p < 0.01, and +++/###/∗∗∗p < 0.001
were considered to be significant (ns, not significant). Bars represent standard error of the mean (SEM). ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 were considered
to be significant (ns, not significant).
and Sirt6 expression was induced by infection (Figure 2). The
relative expression of Nampt and Sirt6 in mCMV-infected NIH-
3T3 and p53 mouse embryonic fibroblasts (p53-MEFs) was
measured using Quantitative reverse-transcriptase Polymerase
Chain Reaction (qRT-PCR) (Figures 2A,B). mCMV infection of
NIH-3T3 and p53-MEFs resulted in significantly higher levels of
Nampt expression during the first 6 h of infection (Figures 2A,B).
While an early increased Sirt6 expression was not observed, a
significantly higher expression was observed in NIH-3T3 after
10 h of infection, indicating a delayed response. Similarly, the
temporal expression profiles (over 24 h) of Nampt and Sirt6
were investigated in mCMV infected bone marrow derived
macrophages (BMDM). Following mCMV infection, cells were
harvested every 2 h until 10 h post-treatment [0 (0 h after
viral adsorption or poly(I:C) treatment), 2, 4, 6, 8, 10 h] and at
24 h, followed by transcriptomic profiling and modeling of their
temporal expression. In these experiments, polynomial fitting
of the smoothened data was used to determine whether the
expression profiles of Nampt and Sirt6 changed significantly
(where a R2 > 0.9 indicated significant change) with time in
infected BMDM (Supplementary Tables S5, S6). In addition
further statistical evaluation was performed by determining the
p-value of the fitted model in relation to a horizontal flat
line, where a significant p-value predicted a temporal change
and a non-significant p-value is predicted of non-fluctuation
in expression. Consistent with the observations in NIH-3T3s
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and p53-MEFs, mCMV infection of BMDM resulted in a
significant early and dynamic expression of Nampt (Figure 2C
and Supplementary Table S5), with a peak at 5 h, followed by a
steady decline. Moreover, similarly to the observations in NIH-
3T3s and p53-MEFs, temporal expression analysis revealed that
mCMV infected BMDM exhibited a delayed but continuous,
albeit lower than Nampt, significant Sirt6 expression (Figure 2C
and Supplementary Table S6). Collectively, these results show
that while Nampt and Sirt6 are both induced in response
to mCMV infection, their response time differs from each
other irrespective of cell type, indicative of potential differential
transcriptional regulation.
Nampt Gene Expression Is Activated by
the Jak/Stat Signaling Pathway and
Induced by Both Type-I and Type-II IFNs,
While Respone of Sirt6 Is Indirect or
Restricted to Type-I IFN Response
The presence of the several putative STAT1 binding sites in
the Nampt promoter region suggests that Nampt expression is
induced in a JAK/STAT signaling pathway-dependent manner.
To initially investigate this, the synthesis of Nampt mRNA was
measured Tyk-2-deficient BMDM (Figure 3). Nampt mRNA
synthesis was investigated in mCMV infected wild-type and
Tyk2-deficient BMDM at 1–1.5 h post-infection and at 6–6.5 h
post-infection (Figure 3A). The non-receptor tyrosine-protein
kinase Tyk2 has been implicated in type-I IFN, IL-6, IL-10, and
IL-12 signaling (Velazquez et al., 1992; Stahl et al., 1994; Heinrich
et al., 1998; Shimoda et al., 2000; Shaw et al., 2006). Consistent
with the identification of putative STAT1 binding sites, mCMV
infection of Tyk2-deficient (Tyk2−/−) BMDM resulted in a
much-reduced Nampt synthesis, compared to infected wild-type
cells, suggesting that Nampt is, at least partly, induced in a
JAK/STAT pathway-dependent manner (Figure 3A).
The presence of putative STAT1 binding sites and the observed
dependence of Nampt expression on TYK2 and on the JAK/STAT
signaling pathway poses the question Whether the induced
expression of Nampt and Sirt6 is dependent on type I IFN
signaling? To investigate this, the expression of Nampt and
Sirt6 was assessed in polyinosinic:polycytidylic acid [poly(I:C)]
treated Ifnb-deficient BMDM and compared to the response in
mCMV infected Ifnb1-deficient (C57BL/6J Ifnb1−/−) BMDM
(Figures 3B,C). Poly(I:C), a ligand of Toll like receptor 3
(TLR3), is structurally similar to double-stranded RNA and
is, thus, used to simulate viral infections. Following mCMV
infection or poly(I:C) treatment, cells were, as decribed above
(Figure 2), harvested every 2 h until 10 h post-treatment and
at 24 h, followed by transcriptomic profiling and modeling of
their temporal expression. As in Figure 2C, mCMV infection
of wild-type BMDM resulted in an early dynamic expression of
Nampt. Similar to Nampt, mCMV infection of wild-type BMDM
significantly induced, albeit at a lower level, the expression
of Sirt6 expression peaking downstream of Nampt. Poly(I:C)
treatment of wild-type BMDM, resulted in a significant temporal
activation of both Nampt and Sirt6, indicating that the observed
expression is a host-driven response to infection (Figure 3C and
Supplementary Tables S7, S8). The level of Nampt activation
following mCMV infection was significantly reduced in Ifnb1-
deficient cells, suggesting that a robust Nampt expression
response is IFNβ-dependent (Figure 3B). While the robustness
in Nampt expression was lost, a small significant temporal change
in the expression profile was observed, suggesting that Nampt
expression is possibly governed by other factors or pathways
including by other type I Ifns but that the magnitude of
expression is strongly dependent on intact IFNβ-signaling. The
early expression of Sirt6 was, however, not extensively altered
in mCMV infected or poly(I:C) treated Ifnb-deficient cells. The
expression was similar to wild-type cells up until 7 h post-
infection and up until 5 h post-poly(I:C) treatment. This was
followed by a reduction in expression, indicating that early but
not late activation of Sirt6 expression following mCMV infection
and poly(I:C) treatment is induced independently of IFNβ
(Figures 3B,C and Supplementary Tables S6, S8). Together,
these results indicate that Nampt and partially Sirt6 are coupled
to the type I IFN response in macrophages.
Further in our BMDM, where stimulation with physiologically
relevant concentration of IFNγ has been previously determined
(Kropp et al., 2011), IFNγ induced the expression of Nampt,
peaking at 6 h post-treatment (Supplementary Figure S1 and
Table S9). Moreover, to further investigate the dependence
of Nampt and Sirt6 expression on the type-II IFN response,
the level of newly transcribed Nampt and Sirt6 mRNA was
measured every 30 min, over a period of 8 h, using reverse
transcriptase-quantitative PCR (qRT-PCR) in BMDM stimulated
with IFNγ (Figure 3D). Stimulation with IFNγ resulted, after 2 h
of infection, in an eight-times increase in de novo transcribed
Nampt RNA levels, followed by a rapid drop in Nampt mRNA.
Sirt6 mRNA levels were on the other hand not affected by
IFNγ stimulation, further suggesting that it is not a type-II
IFN stimulated gene. Notably, the increase in Nampt mRNA
expression was followed by a drop in Srebf2 expression, consistent
with previously published data from Blanc et al. (2011).
The dependence on type-II IFN and JAK/STAT signaling was
further investigated in wild-type and Stat1-deficient (Stat1−/−)
p53-MEFs stimulated with IFNγ (Figures 3E,F). Steady state
levels of Nampt mRNA was investigated at 1, 2, 4, 8, and 16 h
post-treatment and compared to untreated (0 h) cells (Figure 3E).
IFNγ activated of wild-type cells resulted, as early as 2 h post-
treatment, in a significantly increased expression of Nampt
compared to untreated cells (statistical significance depicted with
#), suggesting that Nampt is a type-I IFN responsive gene. In
the IFNγ activated Stat1-deficient (Stat1−/−) cells, a significantly
increased Nampt expression, compared to the untreated Stat1-
deficient control (not shown), was only observed at later time
points (16 h). This expression was significantly reduced at all
time points compared to activated wild-type cells, indicating that
Nampt is dependent on intact Stat1 signaling, consistent with the
identification of putative STAT1 binding sites within the Nampt
promoter region.
Moreover, loss of Stat1 resulted in a significantly reduced
expression of Sirt6 compared to the wild-type p53-MEFs
(Figure 3F). Notably, unlike Nampt, Sirt6 mRNA expression in
wild-type cells did not increase statistically with time (compared
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FIGURE 3 | Expression of Nampt is induced by both type-I and type-II IFN, while respone of Sirt6 is restricted to type-I IFN response. (A) Quantification of Nampt
mRNA expression, using microarray, in wild-type (wt) and Tyk2−/− BMDM following mock- (control) and mCMV-infection. (B) Normalized temporal expression
(antilog) of Nampt and Sirt6 in mCMV infected wild-type and Ifnb−/− BMDM. The expression was measured over the first 24 h of infection using microarray and
compared to timepoint 0. The expression levels between timepoints 0–10 h post-streatment were smoothened and fitted to a linear (+), quadatic (#), or cubic (∗)
polynomal on time to assess significance (p-values). +/#/∗p < 0.05, ++/##/∗∗p < 0.01, and +++/###/∗∗∗p < 0.001 were considered to be significant (ns, not
significant). (C) Normalized temporal expression (antilog) of Nampt and Sirt6 in poly(I:C) treated wild-type and Ifnb−/− BMDM. The expression was measured over
the first 24 h using microarray and compared to timepoint 0. The expression levels between timepoints 0–10 h post-streatment were smoothened and fitted to a
linear (+), quadatic (#), or cubic (∗) polynomal on time to assess significance (p-values). +/#/∗p < 0.05, ++/##/∗∗p < 0.01, and +++/###/∗∗∗p < 0.001 were
considered to be significant (ns, not significant). (D) Quantification of de novo synthesis of Nampt, Sirt6, and Srebf2 mRNA in IFNγ-stimulated BMDMs using
qRT-PCR. Expression was measured every 30 min for a total of 8 h. (E) Quantification of relative Nampt mRNA expression in wild-type and Stat1−/− p53-MEF cells,
at 1, 2, 4, 8, and 16 h, using RT-qPCR following IFNγ stimulation (n = 3). Expression is relative to wild-type untreated (0 h) cells, set as 1 (not shown). One-way
ANOVA with a Tukey’s post-test was used to assess statistical signficance to untreated controls. One-way ANOVA with a Sidak’s multiple comparisons test was
used to assess statistical signficance between wild-type and Stat1−/− mutants. Bars represent SEM. Statisical significance between groups (wild-type and
Stat1−/−) were depicted with ∗. Statistical significance in relation to untreated controls (wild-type and Stat1−/−, respectively) were depicted with #. ∗/#p < 0.05,
∗∗/##p < 0.01, ∗∗∗/###p < 0.001 were considered to be significant. (F) Quantification of relative Sirt6 mRNA expression in wild-type and Stat1−/− p53-MEF cells, at
1, 2, 4, 8, and 16 h, using RT-qPCR following IFNγ stimulation (n = 3). Expression is relative to wild-type untreated (0 h) cells, set as 1 (not shown). One-way ANOVA
with a Tukey’s post-test was used to assess statistical signficance to untreated controls. One-way ANOVA with a Sidak’s multiple comparisons test was used to
assess statistical signficance between wild-type and Stat1−/− mutants. Bars represent SEM. Statisical significance between groups (wild-type and Stat1−/−) were
depicted with ∗. Statistical significance in relation to untreated controls (wild-type and Stat1−/−, respectively) were depicted with #. ∗/#p < 0.05, ∗∗/##p < 0.01,
∗∗∗/###p < 0.001 were considered to be significant.
to untreated control), suggesting that it is not a type-II IFN
stimulated gene. Nor did the expression change significantly
in Stat1-deficient cells to the respective untreated control. It
is possible to speculate that Stat1 signaling is required for
the basal, but not induced, Sirt6 expression. The absence of
identified STAT1 binding sites in combination with the absence
of gene induction with time further support the notion that this
activation is indirect. Collectively, these results show that Nampt
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and Sirt6 are both induced in response to mCMV infection and
suggest that Nampt is an interferon-stimulated gene (ISG), with
Nampt expression being an immediate-response gene induced by
type-I and type-II IFN in a JAK/STAT dependent manner.
Intact Type-I IFN Signaling Is Required
for Strong Infection-Induced Expression
of Upstream, but Not Downstream, TLR
Signaling Pathway Components
Infection with double-stranded DNA viruses, such as CMV,
are known to trigger the common TLR signaling pathway that
elicits the activation of NFκB and MAPK through the Myd88
adaptor (Compton et al., 2003), while other pathways, such as
the IPS-1 and STING mediated pathways, induce type-I IFN
synthesis (Seth et al., 2005; Cheng et al., 2007; Ishikawa et al.,
2009) resulting in downstream target activation. To explore
the gene activation of factors belonging to these pathways,
the temporal gene expression profiles of Myd88, p50 (Nfκb1),
p65 (Rela), Trif (Ticam1), Rig-I (Ddx58), Mda5 (Ifih1), Ips-1
(Mavs), Sting (Tmem173), and cGas (Md21d1) were investigated
in mCMV infected or poly(I:C) treated wild-type and Ifnb1-
deficient BMDM (Figure 4 and Supplementary Tables S10–S27).
Following mCMV infection of wild-type BMDM, a significant
temporal activation of Myd88, p50, p65, Trif, Rig-I, Mda5, and
Sting was observed (Figure 4A). The expression profile of Ips-1
was initially suppressed up until 5 h post-infection followed by
an activation, while cGas exhibited an early activation between 1
and 3 h post-infection, followed by a rapid drop in expression.
Notably, the activation of Trif, which was absent until 3 h
post-infection, was followed by a rapid increase in expression
peaking at 7 h. In Ifnb1-deficient BMDM, mCMV infection
resulted in a significant temporal change in expression of all
genes but Trif. While the temporal expression of Myd88, Rig-
I, Mda-5, and Sting was significantly changed over time, the
level of expression was much reduced in these cells, suggesting
that IFNβ-signaling is in part needed for the full induction of
these genes. Notably, while the expression level of cGas was
initially much higher in wild-type cells, the level expression after
5 h dropped to similar levels as those observed in the Ifnb1-
deficient cells, suggesting that IFNβ is required for the early
activation of this gene.
In poly(I:C) activated wild-type BMDM, significant temporal
expression change was observed for Myd88, p65, Trif, Rig-I, Ips-1,
and cGas, consistent with that observed in mCMV infected cells
(Figure 4B). p50, Mda5, and Sting all exhibited an initial increase
in expression between 1 and 3 h post-treatment, however, unlike
Mda5 and Sting that did not significantly change, the level of
p50 expression was reduced between 3 and 7 h. The modeled
temporal change in the p50 expression profile was, however,
not significant. In Ifnb1-deficient BMDM, a significant temporal
change was observed for all genes with the exception of Trif. As
in infected Ifnb1-deficient BMDM, poly(I:C) treatment resulted
in a reduced temporal expression for Myd88, Rig-I, Mda-5, and
Sting. Moreover, Mda5 exhibited a repressed temporal profile, as
compared to its expression in poly(I:C) treated wild-type cells.
Notably, Ips-1 and cGas both exhibited an increased expression
over time, with the expression of Ips-1 exceeding that observed in
wild-type cells (Figure 4B).
Collectively, these results suggest intact IFNβ-signaling is not
required for the expression of p50 and p65 following mCMV
infection, but is required for the magnitude in expression of
the upstream components (Myd88, Rig-I, Mda5, and Sting)
of these pathways.
Inhibition of SIRT6 and NAMPT Results
in Increased Viral Replication
The observation that Nampt and Sirt6 were coordinately induced
in macrophages by immune stimulation, either by infection or
the ensuing interferon response, prompted us to test whether
NAMPT and SIRT6 exhibit antiviral activity. To investigate
whether Sirt6 and Nampt exhibit antiviral properties, mCMV
replication was measured after siRNA mediated knockdown of
Sirt6 and after pharmacologic inhibition or siRNA mediated
knockdown of Nampt, with the highly specific non-competitive
inhibitor FK866, respectively (Hasmann and Schemainda, 2003)
(Figure 5 and Supplementary Figure S2). Consistent with the
reported antiviral activity of human SIRT6 (Koyuncu et al.,
2014), mediated knockdown of murine Sirt6 resulted, in a
siRNA concentration-dependent manner, in an increased viral
replication (Figure 5A). Moreover, siRNA mediated knockdown
and pharmacologic inhibition of murine Nampt also resulted
in an increase in viral replication, respectively (Figures 5B,C).
Together, these results indicate that Sirt6 and Nampt both display
antiviral properties, providing druggable targets in bolstering
interferon antiviral immunity linked to sterol metabolism.
DISCUSSION
Here, we demonstrate upon infection of macrophages the serial
activation of Nampt and Sirt6. The observed rapid kinetics
of Nampt induction shows a strict dependency on both type
I and type II IFN signal activation of transcription and,
thus, represents an immediate-early class of ISG. By contrast
Sirt6 shows delayed induction kinetics and is only indirectly
activated downstream of viral induced type I IFN signaling.
In agreement, we find the Nampt promoter region contains
multiple consensus Stat1 binding sites whereas these sites are
absent in the Sirt6 promoter region. Notably, pharmacological
inhibition of NAMPT enzymatic activity or knock-down of
Nampt or Sirt6 result in increased viral replication revealing anti-
viral roles for these metabolic regulators in infection. Hence,
in an apparent orchestrated and coordinated manner Nampt
enzymatically drives NAD+ production that is a key rate-limiting
co-factor for Sirt6 activation and thereby couples Sirt6 functions
to the IFN antiviral response (Figure 6).
We further find that temporal expression analysis of key
pathway components of the common TLR signaling pathway,
which elicits the activation of NFκB and MAPK through the
Myd88 adaptor (Compton et al., 2003), and the IPS-1 and STING
mediated pathways that induce type-I IFN synthesis, revealed
a part dependency on intact type I IFN signaling as loss of
Ifnb1 resulted in a reduced magnitude of expression (Myd88,
Frontiers in Microbiology | www.frontiersin.org 6 March 2019 | Volume 10 | Article 355
fmicb-10-00355 February 28, 2019 Time: 19:45 # 7
Dantoft et al. Metabolic Epigenetic Control of Infection
FIGURE 4 | Expression of upstream, but not downstream, TLR signaling pathway components is dependent on IFNβ/type-I IFN signaling. (A) Normalized temporal
expression (antilog) of Myd88, p50 (Nfkb1), p65 (Rela), Trif (Ticam1), Rig-I (Ddx58), Mda-5 (Ifih1), Ips-1 (Mavs), Sting (Tmem173), and cGas (Mb21d1) in mCMV
infected wild-type and Ifnb−/− BMDM. The expression was measured over the first 24 h of infection using microarray and compared to timepoint 0. The expression
levels between timepoints 0–10 h post-streatment were smoothened and fitted to a linear (+), quadatic (#), or cubic (∗) polynomal on time to assess significance
(p-values). +/#/∗p < 0.05, ++/##/∗∗p < 0.01, and +++/###/∗∗∗p < 0.001 were considered to be significant (ns, not significant). (B) Normalized temporal expression
(antilog) of Myd88, p50 (Nfkb1), p65 (Rela), Trif (Ticam1), Rig-I (Ddx58), Mda-5 (Ifih1), Ips-1 (Mavs), Sting (Tmem173), and cGas (Mb21d1) in poly(I:C) treated
wild-type and Ifnb−/− BMDM. The expression was measured, as in (A), over the first 24 h using microarray and compared to timepoint 0. The expression levels
between timepoints 0–10 h post-streatment were smoothened and fitted to a linear (+), quadatic (#), or cubic (∗) polynomal on time to assess significance (p-values).
+/#/∗p < 0.05, ++/##/∗∗p < 0.01, and +++/###/∗∗∗p < 0.001 were considered to be significant (ns, not significant).
Rig-I, Mda5, and Sting). The downstream signaling components
of these pathways, p50, p65, Trif, Ips-1, and cGas were on the
other hand not affected in the same way by the loss of Ifnb1.
An activated expression profile was, however, observed for Ips-
1 and cGas, suggesting that intact type I IFN signaling might
be required for maintaining a regulated expression of these
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FIGURE 5 | Inhibition of NAMPT and SIRT6 activity increases viral loads in MCMV infected cells. (A) Normalized replication slope of mCMV-GFP in Sirt6
siRNA-treated NIH-3T3. “RISC-free” siRNA served as negative control and miR342-5p siRNA served as positive control. (B) Normalized replication slope of
mCMV-GFP in Nampt siRNA-treated NIH-3T3, with M54 serving as positive control. Bars represent SEM. Statistical significance was determined using One-way
ANOVA with a Dunnett’s multiple comparisons test. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 were considered to be significant (ns, not significant). (C) mCMV-GFP
replication (titer) in NIH-3T3 after pharmacological inhibition of NAMPT with FK866 (10 nM final concentration). mCMV-GFP was propagated in NIH-3T3 fibroblasts
and quantified by plaque assay on p53-MEF monolayers in 48-well plates. Statistical significance was determined using unpaired t-test with Welch’s correction.
∗p < 0.05 was considered to be significant.
FIGURE 6 | Summary figure.
genes. As for p50 (NFκB), an initial increased expression was
observed followed by a gradual (mCMV infection) or rapid
(poly(I:C) treatment) declining expression. A similar expression
profile was observed for p65 following mCMV infection, but
not poly(I:C) treatment. Notably, in recent years, SIRT6 has
been shown to inhibit NFκB expression (Kawahara et al., 2009;
Santos-Barriopedro and Vaquero, 2018; Santos-Barriopedro
et al., 2018) and NFκB target gene activation by interacting with
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p65 (Figure 6) (Li et al., 2018; Santos-Barriopedro and Vaquero,
2018). It is possible that this mode of regulation is reflected
in the observed p50 and p65 expression profiles, nevertheless,
further analysis would be required to confirm this. Whether Sirt6
is regulated by NFκB in this system remains to be explored,
however, global profiling of p65 binding sites (by ChIP-seq) in
TNFα-induced human osteosarcoma U-2 OS cells (Janus et al.,
2018) and TNFα-induced or poly(I:C) stimulated Detroit 562
cells (Borghini et al., 2018) did not identify SIRT6 as a NFκB/p65
target gene. Genome-wide profiling of p65-bound sites after 3 and
6 h of LPS treatment, have on the other hand identified NAMPT
as a p65-activated gene (Lim et al., 2007).
Together, these findings are consistent with observations, in
other systems, that are supportive of a potential antiviral role
for Nampt and Sirt6 (Schoggins et al., 2011; Van den Bergh
et al., 2012; Chen et al., 2013; Koyuncu et al., 2014; Zhang
et al., 2014; Li et al., 2018). In a systems-level screen for ISGs
with antiviral activity, human NAMPT was identified as one
of several type-I ISGs that exhibited, in infected Huh-7 cells,
antiviral activity toward Venezuelan equine encephalitis virus
(VEEV), a single-stranded RNA virus (Schoggins et al., 2011).
NAMPT has also been reported to exhibit anti-HIV-1 activity,
interfering with both early events of the life cycle (Van den Bergh
et al., 2010) and Tat-induced HIV-1 long terminal repeat (LTR)
transactivation (Zhang et al., 2010; Chen et al., 2013; Zhang et al.,
2014). As for the role of SIRT6 in antiviral immunity this is
less known. Koyuncu et al. (2014) reported in a loss-of-function
study, that loss of human Sirtuin activity, including SIRT6
activity, in infected fibroblast MRC5 cells resulted, by unknown
mechanism, in significant increases in viral titers (hCMV, HSV-
1, Adenovirus, and Influenza A). Moreover, a recent report by Li
et al. (2018) show that SIRT6 negatively regulates Dengue virus-
induced inflammatory responses by targeting the DNA binding
domain of NFκB p65. Notably, unlike our observations reported
here those reported by Koyuncu et al. (2014), DENV replication
was reduced in HEK293T cells upon silencing of SIRT6 (Li
et al., 2018). It is possible that with the diverse nature of SIRT6
the mechanisms by which it exerts its antiviral function differs
depending on cell type and viral strain, though the mechanism
by which Nampt and Sirt6 exert antiviral effects in these studies is
not known. Nevertheless, together with our findings they support
the notion that NAMPT and SIRT6 constitute yet another way by
which the macrophage can limit productive viral infection.
A central mechanism of action worth noting is the reciprocal
increase in de novo Nampt mRNA expression, in IFNγ stimulated
BMDM, is followed by a decrease in Srebf2 transcription.
This is consistent with studies demonstrating IFN-antiviral
suppression of transcription of multiple members of the sterol
biosynthesis pathway, in part mediated by a drop in SREBP2 RNA
transcription and protein levels (Blanc et al., 2011). Mechanistic
studies of IFN suppression of macrophage sterol biosynthesis
pathway have determined an approximately 40% contribution
by Ch25h and its cognate metabolite 25HC acting at the post-
translational level, and 40% by a post-transcriptional mechanism
involving microRNA (miR342-5p). However, these known
mechanisms fail to account for the observed transcriptional
effects on Srebf2 levels. In this regard, there is good evidence to
show that Sirt6 binds to and regulates Srebf2 via transcription (Lu
et al., 2015; Robertson et al., 2016). Figure 6 shows a schematic of
a proposed mechanism for the anti-viral activies of Nampt and
Sirt6, mediated through epigentic transcriptional suppression
of Srebf2, which encodes the master TF sterol biosynthesis.
Figure 6 also highlights the other proposed molecular pathways
for down-regulating the sterol pathway in macrophages involving
the generation of 25-hydroxycholesterol (25HC) and miR342-
5p microRNA, both of which contribute toward modulating the
SREBP2 autoregulatory loop in response to interferon-signaling
(Reboldi et al., 2014; Robertson et al., 2016).
It is noteworthy that host-directed targeting of immune
modulated cellular pathways can be used as an innovative
therapeutic intervention that also overcomes the antiviral drug
resistance (Ghazal et al., 2000). In this regard, we note that
SIRT6 inhibitors are under development as anti-cancer drugs
(Hu et al., 2014; Parenti et al., 2014; Sociali et al., 2015). Some
studies have investigated the efficiency of Ex527 (Selisistat), a
commercially available Sirtuin inhibitor (Sigma-Aldrich) (Lugrin
et al., 2013; Ekblad and Schüler, 2016) and another proposed
approach in inhibiting SIRT6 activity is through administration
of nicotineamide (NAM/Vitamin B3), which in addition to being
a NAD+ precursor, also acts as an endogenous, non-competitive
Sirtuin inhibitor (Bitterman et al., 2002). Thus, there is an
opportunity for repurposing these cancer drugs for potential
antiviral therapy.
MATERIALS AND METHODS
Mice
C57BL/6 mice were housed in the specific pathogen-free
animal facility at the University of Edinburgh. Tyk2−/− mice
were maintained under specific-pathogen-free conditions at the
Institute of Animal Breeding and Genetics, Department for
Biomedical Sciences, University of Veterinary Medicine Vienna,
Vienna, Austria. The generation or source of knockout mouse
strains for Tyk2−/− has been described before (Strobl et al.,
2005). All procedures were carried out under project and personal
licenses approved by the Secretary of State for the Home
Office, under the United Kingdom’s 1986 Animals (Scientific
Procedures) Act and the Local Ethical Review Committee at
Edinburgh University.
Cell Propagation and Culture
NIH-3T3 (ATCC R© CRL-1658TM) immortalized cell line of
embryonic mouse fibroblasts was obtained from American
Type Culture Collection (ATCC) (Manassas, VA, United States)
and grown in Dulbecco’s modified Eagle medium (DMEM)
(Lonza, Verviers, Belgium), supplemented with 5% Calf Serum
(CS) (Thermo Fisher Scientific, Waltham, MA, United States),
2 mM glutamine (Lonza) and 50 U/ml of penicillin/streptomycin
(Lonza). The p53-MEF immortalized cell lines, of p53−/−
embryonic mouse fibroblasts [p53-MEFs, MB355 (ATCC R© CRT-
2818TM)] was obtained from American Type Culture Collection
(ATCC) (Manassas, VA, United States). p53-MEFs and Stat1−/−
p53-MEFs were grown in DMEM (Lonza), supplemented with
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5% fetal calf serum (FCS) (Thermo Fisher Scientific), 2 mM
glutamine (Lonza) and 100 U/ml of penicillin/streptomycin
(Lonza). BMDM were isolated and grown in DMEM/F-12 (Ham
1:1) and L-glutaMAX, supplemented with 10% Fetal Calf Serum
(Lonza), 10% L929 and 100 U/ml of penicillin/streptomycin. All
cells were grown in accordance to standard procedures. BMDMs
were differentiated with CSF-1 derived from L929 cells for 7 days
prior to further treatment.
Viruses and Reporter Viruses
Wild-type murine cytomegalovirus (MCMV-C3X) has been
previously described (Messerle et al., 2000). The GFP-encoding
MCMV (mCMV-GFP) has also been previously described
(Angulo et al., 2000). For RNA expression analysis, infection was
done at a multiplicity of index (MOI) of 1 unless else specified.
RNAi and Assay for GFP-Virus Growth
Small interfering RNA and “RISC-free” control siRNA
were purchased from Dharmacon R© RNAi Technologies
(Thermo Fisher Scientific). miR-342-5p microRNA mimic
were kindly gifted by Integrated DNA Technologies
(WOS:000332467100005). The following siRNAs were used:
“RISC-free” siRNA, SiGenomeTM Control (Cat. No. D-001220-
01-05); Mouse Sirt6 siRNA (deconvoluted), ON-TARGETplus
siRNA Mouse Sirt6 (Cat. No. J-061392-09, J-061392-10, J-
061392-11, J-061392-12); Mouse Nampt siRNA (deconvoluted),
ON-TARGETplus siRNA Mouse Nampt (Cat. No. J-040272-09,
J-040272-10, J-040272-11, J-040272-12); M54 siRNA, custom
made order from Dharmacon R© (5′–3′ sense strand sequence
is AGAAAGACGACCTGAGCTA). Mimics and siRNA were
transfected into cells (NIH-3T3), in a 96 well plate, using
DharmaFECT1 (Thermo Fisher Scientific) using the reverse-
transfection method and in accordance to the manufacturer’s
recommendations. M54 siRNA and miR-342-5p microRNA
mimic were transfected at a final concentration of 25 nM and
Sirt6 siRNA was transfected at a final concentration of 6.25, 12.5,
and 25 nM/well. For the analysis of miR-342-5p inhibitor effects
on virus replication, medium containing 3% delipidized serum
[Bovine Serum, Lipid Depleted (Part number: S181L), VWR,
United Kingdom] was used. After 48 h, MCMV-GFP (MOI
0.025) was used for infection. The viral growth (fluorescence
in each well) was measured using a POLARstar OPTIMA plate
reader (BMG Labtech, Aylesbury, United Kingdom) according
to manufacturer’s recommendations. The RNAi and viral growth
assay were set up as two independent experiments with 3
biological replicates per experiment (n = 6). Virus replication
slopes over the linear phase were calculated, from 68 h to the end
of the time course, and then normalized to control transfected
wells. Statistical significance was determined using One-way
ANOVA with a Dunnett’s multiple comparisons test. p-Values of
<0.05, <0.01, and <0.001 were considered significant.
In silico Promoter Analysis
In silico promoter analysis of the NAMPT and SIRT6 promoter
regions was done using PROMO, a virtual laboratory for
identification of putative transcriptional binding sites (Messeguer
et al., 2002; Farré et al., 2003). The promoter regions consisting
of the 1 kb upstream regions of murine and human NAMPT
and SIRT6 were retrieved from the Mouse Genome Informatics
(MGI) Web Site (Bult et al., 2015; Finger et al., 2017; Smith et al.,
2018) and The National Center for Biotechnology Information
(NCBI) (Geer et al., 2010) resource, and imported into the
online PROMO analysis tool. Species specific (Mus musculus
or Homo sapiens) TFs and TF sites were chosen. For murine
Nampt and Sirt6, 306, and 270 putative TF binding sites within a
dissimilarity margin less or equal than 15% were identified in the
promoter regions, respectively. For human NAMPT and SIRT6,
444 and 436 putative TF binding sites within a dissimilarity
margin less or equal than 15% were identified in the promoter
regions, respectively. All identified putative binding sites can
be found in Supplementary Tables S1–S4. From these, the
most probably immune-regulatory and core TF binding sites
were identified via manual procurement by comparing putative
binding site to publicly available/published consensus binding
sequences for each TF.
IFN-γ Treatment of p53-MEFs and
Isolation
Wild-type and Stat1−/− p53-MEFs were plated, in a 24-well
plate, at a cell density of 3 × 105 cells/well and grown
in DMEM (Lonza), supplemented with 5% FCS (Thermo
Fisher Scientific), 2 mM glutamine (Lonza) and 100 U/ml of
penicillin/streptomycin (Lonza), for 24 h prior to treatment with
murine recombinant IFN gamma (IFNγ) and (Perbio Science).
The IFNγ was diluted in complete medium and added to cells at
a final concentration of 10 U/ml. Cells were harvested at 1, 2, 4, 8,
and 16 h post-treatment for quantitative real-time PCR analysis
using 350 µl Qiagen RTL Plus buffer (Qiagen RNeasy Plus kit) as
per manufacturer’s recommendations.
BMDM IFN-γ Treatment, RNA Labeling,
and Isolation
Incorporation of 4-thiouridine (Sigma-Aldrich, St. Louis, MI,
United States) into newly-transcribed RNA was undertaken as
described by Dölken et al. (2008) and Robertson et al. (2016).
In brief, at time zero medium was aspirated from all plates
and 15 ml of pre-warmed medium containing IFN-γ (final
concentration of 10 U/ml) or normal medium was added to
the cultures. RNA labeling in BMDM during the first 30 min
of the time course was undertaken by addition of 200 µM
4-Thiouridine to the medium of appropriate plates at this
time. After 30 min, to end the RNA labeling period, terminate
transcription and lyse the cells, medium was aspirated from
the labeled BMDM and replaced with 4 ml of RLT lysis buffer
(Qiagen, Hilden, DE, United States). In parallel, 10 ml of medium
from the next BMDM cultures to be labeled was added to an
appropriate volume of 4-thiouridine, mixed and immediately
added back to the plate. BMDM cultures were then returned
to the incubator. The above cycle of 4-thiouridine addition to
BMDM cultures and transcriptional termination was repeated
at 30-min intervals until the end of the time course. Total
RNA was isolated using RNeasy Midi kit (Qiagen) according
to manufacturer’s instructions, quantitated using a Nanodrop
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(Thermo Scientific) and integrity was confirmed using an Agilent
Bioanalyser (Agilent United Kingdom). Newly transcribed RNA
(ntRNA) was then isolated as described in Dölken et al. (2008)
and Robertson et al. (2016) and again quantitated using a
Nanodrop, followed by qRT-PCR.
Quantitative Real-Time PCR (qRT-PCR)
Analyses of Individual Genes
Cells were harvested in 350 µl Qiagen RTL Plus buffer (Qiagen
RNeasy Plus kit) as per manufacturer’s recommendations. Total
RNA was extracted from cells with RNeasy Plus kit (Qiagen)
according to the manufacturer’s instructions and quantitated
using a Nanodrop (Thermo Scientific). All experiments
were performed on three biological replicates/samples
(n = 3) and expression analysis were performed with three
technical replicates/sample (n = 3), unless else specified.
Quantitative gene-expression analyses were performed using
Taqman R© Primer probe sets (Applied Biosystems, Warrington,
United Kingdom). Mouse Assay ID: NAMPT: Mm00451938_m1,
SIRT6: Mm01149042_m1, SREBF2: Hs01081784_m1, Actin Beta
(ACTB FAM): Mm02619580_g1. Quantitative real-time PCR
was performed either as one-step reactions (qRT-PCR) or
two-step reactions (RT-qPCR) with an initial separate cDNA
synthesis step. qRT-PCR and RT-qPCR were performed in a
Stratagene MX3000P machine (Stratagene California, San Diego,
CA, United States). For qRT-PCR, each sample reaction was
performed in 10 µl volumes using 96-well Non-Skirted, White
PCR Plates (ABgene, United Kingdom) and MicroAmp Optical
Caps (Applied Biosystems, United Kingdom). For one reaction,
50 ng of diluted total RNA samples was added to 2.5 µl of 4x
qScript One-Step Fast qRT-PCR (Low ROX) master-mix, 0.5 µl
qScript One-step Reverse Transcriptase (Cat. No. 95081, Quanta
Biosciences, United States), 0.5 µl of Taqman primer/probe set
(Applied Biosystems), and RNase-free H2O to a total volume of
10 µl. cDNA synthesis by reverse-transcription was performed
at 50◦C for 5 min, followed by initial denaturation at 95◦C for
30 s, and 40 cycles of combined denaturation at 95◦C for 3 s
followed by annealing/primer extension (detection) at 60◦C for
30 s. For two-step analysis, 500 ng of isolated total RNA was used
for cDNA synthesis with random hexamers using SuperScript R©
III Reverse Transcriptase (Thermo Fisher Scientific) following
the manufacturer’s instructions. Following cDNA synthesis,
qPCR was performed in 10 µl volumes. For one reaction, 50 ng
cDNA (equivalent to 50 ng total RNA) was added to 5 µl of
2x PerfeCta R© qPCR ToughMixTM (Low ROX) master-mix,
0.5 µl of Taqman primer/probe set (Applied Biosystems), and
RNase-free H2O to a total volume of 10 µl. Expression of target
genes was normalized to ActB. The normalized data were used
to quantify the relative levels of a given mRNA according to
comparative cycle threshold (2−11CT) analysis (Livak and
Schmittgen, 2001; Schmittgen and Livak, 2008). Statistical
significance in Nampt and Sirt6 expression was calculated using
One-way ANOVA with a Tukey’s or Sidak’s multiple comparisons
test (between wild-type and Stat1−/− p53-MEFs). Statistical
significance for knock-down efficiency of Nampt and Sirt6 was
determined using One-way ANOVA with a Dunnett’s multiple
comparisons test. p-Values of < 0.05, < 0.01, and < 0.001 were
considered significant.
Pharmacological Inhibition of NAMPT
With FK866 and Viral Plaque Assay
Pharmacological inhibition of NAMPT was done using FK866
(Hasmann and Schemainda, 2003) at a final concentration of
10 mM. Briefly, NIH-3T3 cells were seeded in a 48 well plate at
a cell density of 1 × 105 cells/well and infected with MCMV-
GFP (MOI 0.1) the following day. After the adsorption period,
the infection media was replaced with media with FK866 (10 nM)
or without (control). Cells were assessed for viral growth (GFP
signal) over a 4-day period at which point the cells were harvested
and frozen down at −80◦C. The effect of FK866 treatment
on viral growth was quantified by plaque assay on p53−/−
MEF monolayers in 48-well plates using standard methodology.
Statistical significance was determined using unpaired t-test with
Welch’s correction. p-Values of < 0.05, < 0.01 and < 0.001 were
considered significant.
Time-Course Expression Analysis
Temporal expression analysis for Nampt, Sirt6, and Stat1 in wild-
type and IFNB−/− BMDM are based off previously generated
microarray data published by Blanc et al. (2013). Briefly, wild-
type, and IFNB−/− BMDM were either infected with MCMV
(MOI 1) or treated with or poly(I:C) (25 µg/ml) or IFNγ
(10 U/ml). Cells infected with MCMV or treated with poly(I:C)
were harvested at 0, 2, 4, 6, 8, 10, and 24 h post-treatment for
RNA isolation and microarray analysis (Affymetrix Mouse Gene
1.0ST microarray). Cells treated with IFNγ were harvested every
60 min for a total of 12 h post-treatment for RNA isolation and
microarray analysis (Affymetrix Mouse Gene 1.0ST microarray).
In brief, the arrays were normalized using the gcRMA algorithm
(Wu et al., 2004) and imported into Partek Genomics Suite
(Partek, United States) for downstream analysis (Blanc et al.,
2013). Temporal expression data for Nampt in MCMV-infected
wild-type and Tyk2−/− BMDM was generated using microarray.
BMDM isolated from wild-type and Tyk2−/− mice were
cultivated for 7 days. Following 7 days, cells were infected with
MCMV (MOI 1) and harvested 1–1.5 and 6–6.5 h post-infection
followed by RNA isolation (RNeasy Midi kit, Qiagen) and
microarray analysis (Affymetrix Mouse Gene 1.0ST microarray).
Time course microarray analysis data are compliant with the
National Centre for Biotechnology Information Gene Expression
Omnibus (GEO) (Edgar et al., 2002) under SuperSeries accession
number GSE42505 (SubSeries numbers GSE42503, GSE42504)
(GEO1). Macrophage microarray data of MCMV-infected wild-
type and Tyk2−/− BMDM is accessible through GEO under
accession number GSE126867.
Statistical Analysis of Time-Course Data
Prior to statistical analysis, gene expression data [0–24 h post-
mCMV infection or poly(I:C) treatment] was smoothened by
1http://www.ncbi.nlm.nih.gov/geo/
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taking the mean of every consecutive pair of points, i.e., mean
of score at 0 and 2 h defined the score at 1 (hour) and mean of
2 and 4 h defined the score at 3 (hours), 4 and 6 h defined the
score at 5 (hours), 6 and 8 h defining the score at 7 (hours), and
8 and 10 h defining the score at 9 (hours). Smoothing was not
done beyond 10 h as the gap to the next point at 24 h was too
large and, thus, excluded from analysis. This type of smoothing
preserves the patterns in the data while removing some of the fine
scale rapid changes. To investigate whether the gene expression
changed over time, the mean smoothed data (or non-smoothened
for the 12 h-dataset) for each gene expression was compared
to a straight horizontal line. This was achieved by fitting the
data to an appropriate polynomial in time t, i.e., either a linear
model (y = α+ βt), or a quadratic model (y = α+ βt + γt2) or
a cubic model (y = α+ βt + γt2 + δt3). If the coefficients other
than the intercept (α ) were significant then the model and hence
the gene expression, must vary with time. Which model was
chosen depended on the model fit as given by the R2 value –
the higher the better. The great majority of the fits were very
strong –R2 > 0.9. To determine then if the model deviated
significantly for the horizontal, the significance attached to each
of the coefficients (β, γ, δ) of the time variables was investigated.
If anyone of these was significant at the p< 0.05 level or if any two
were significant at the 0.05< p< 0.1 level then we considered the
model and the gene expression to vary significantly with time.
Refer to Supplementary Tables S5–S27 for the results of the
statistical analysis.
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FIGURE S1 | Nampt expression in macrophages is Jak/Stat-dependent and
induced by IFNγ stimulation. Normalized temporal Nampt expression in
IFNγ-treated BMDM. The expression was measured hourly over the first 12 h of
treatment using microarray, and the expression levels were fitted to a cubic
polynomal on time and assessed for statitical significance (temporal change over
12 h). ###p < 0.001 were considered to be significant.
FIGURE S2 | Knock-down efficiency of Nampt and Sirt6 in NIH-3T3 cells. (A)
Quantification of relative Nampt mRNA expression in NIH-3T3 cells following using
qRT-PCR following siRNA treatment (6.25, 12.5, and 25 nM siRNA) (n = 3). (B)
Quantification of relative Sirt6 mRNA expression in NIH-3T3 cells following using
qRT-PCR following siRNA treatment (6.25, 12.5, and 25 nM siRNA) (n = 3).
One-way ANOVA with a Dunnett’s multiple comparisons test was used to
determine statistical significance. Bars represent standard error of the mean
(SEM). ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 were considered to be
significant (ns, not significant).
TABLE S1 | Putative TF binding in murine Nampt promoter region (−1 kb
upstream of Nampt gene): prediction done with PROMO online based tool.
TABLE S2 | Putative TF binding in murine Sirt6 promoter region (−1 kb upstream
of Sirt6 gene): prediction done with PROMO online based tool.
TABLE S3 | Putative TF binding in human NAMPT promoter region (−1 kb
upstream of NAMPT gene): prediction done with PROMO online based tool.
TABLE S4 | Putative TF binding in human SIRT6 promoter region (−1 kb
upstream of SIRT6 gene): prediction done with PROMO online based tool.
TABLE S5 | Coefficientsa for fit of Nampt expression over time in MCMV
infected BMDM (0–10 h).
TABLE S6 | Coefficientsa for fit of Sirt6 expression over time in MCMV
infected BMDM (0–10 h).
TABLE S7 | Coefficientsa for fit of Nampt expression over time in poly(I:C)
treated BMDM (0–10 h).
TABLE S8 | Coefficientsa for fit of Sirt6 expression over time in poly(I:C)
treated BMDM (0–10 h).
TABLE S9 | Coefficientsa for fit of Nampt expression over time in MCMV
infected BMDM (0–12 h).
TABLE S10 | Coefficientsa for fit of Myd88 expression over time in MCMV
infected BMDM (0–10 h).
TABLE S11 | Coefficientsa for fit of p50 (Nfkb1) expression over time in MCMV
infected BMDM (0–10 h).
TABLE S12 | Coefficientsa for fit of p65 (Rela) expression over time in MCMV
infected BMDM (0–10 h).
TABLE S13 | Coefficientsa for fit of Trif (Ticam1) expression over time in MCMV
infected BMDM (0–10 h).
TABLE S14 | Coefficientsa for fit of Rig-I (Ddx58) expression over time in MCMV
infected BMDM (0–10 h).
TABLE S15 | Coefficientsa for fit of Mda5 (Ifih1) expression over time in MCMV
infected BMDM (0–10 h).
TABLE S16 | Coefficientsa for fit of Ips-1 (Mavs) expression over time in MCMV
infected BMDM (0–10 h).
TABLE S17 | Coefficientsa for fit of Sting (Tmem173) expression over time in
MCMV infected BMDM (0–10 h).
TABLE S18 | Coefficientsa for fit of cGas (Md21d1) expression over time in MCMV
infected BMDM (0–10 h).
TABLE S19 | Coefficientsa for fit of Myd88 expression over time in poly(I:C)
treated BMDM (0–10 h).
TABLE S20 | Coefficientsa for fit of p50 (Nfkb1) expression over time in poly(I:C)
treated BMDM (0–10 h).
TABLE S21 | Coefficientsa for fit of p65 (Rela) expression over time in poly(I:C)
treated BMDM (0–10 h).
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TABLE S22 | Coefficientsa for fit of Trif (Ticam1) expression over time in poly(I:C)
treated BMDM (0–10 h).
TABLE S23 | Coefficientsa for fit of Rig-I (Ddx58) expression over time in poly(I:C)
treated BMDM (0–10 h).
TABLE S24 | Coefficientsa for fit of Mda5 (Ifih1) expression over time in poly(I:C)
treated BMDM (0–10 h).
TABLE S25 | Coefficientsa for fit of Ips-1 (Mavs) expression over time in poly(I:C)
treated BMDM (0–10 h).
TABLE S26 | Coefficientsa for fit of Sting (Tmem173) expression over time in
poly(I:C) treated BMDM (0–10 h).
TABLE S27 | Coefficientsa for fit of cGas (Md21d1) expression over time in
poly(I:C) treated BMDM (0–10 h).
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